These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32577431)
21. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Liu M; Yue Y; Harper SQ; Grange RW; Chamberlain JS; Duan D Mol Ther; 2005 Feb; 11(2):245-56. PubMed ID: 15668136 [TBL] [Abstract][Full Text] [Related]
22. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Yue Y; Li Z; Harper SQ; Davisson RL; Chamberlain JS; Duan D Circulation; 2003 Sep; 108(13):1626-32. PubMed ID: 12952841 [TBL] [Abstract][Full Text] [Related]
23. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques. Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961 [TBL] [Abstract][Full Text] [Related]
24. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Koo T; Popplewell L; Athanasopoulos T; Dickson G Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945 [TBL] [Abstract][Full Text] [Related]
25. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies. Sun J; Hua B; Chen X; Samulski RJ; Li C Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688 [TBL] [Abstract][Full Text] [Related]
26. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914 [TBL] [Abstract][Full Text] [Related]
28. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Athanasopoulos T; Graham IR; Foster H; Dickson G Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965 [TBL] [Abstract][Full Text] [Related]
29. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. Rodino-Klapac LR; Janssen PM; Montgomery CL; Coley BD; Chicoine LG; Clark KR; Mendell JR J Transl Med; 2007 Sep; 5():45. PubMed ID: 17892583 [TBL] [Abstract][Full Text] [Related]
30. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Wang Z; Allen JM; Riddell SR; Gregorevic P; Storb R; Tapscott SJ; Chamberlain JS; Kuhr CS Hum Gene Ther; 2007 Jan; 18(1):18-26. PubMed ID: 17176210 [TBL] [Abstract][Full Text] [Related]
31. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors. Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles. Aubert D; Pichard V; Durand S; Moullier P; Ferry N Hum Gene Ther; 2003 Mar; 14(5):473-81. PubMed ID: 12691612 [TBL] [Abstract][Full Text] [Related]
33. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426 [TBL] [Abstract][Full Text] [Related]
34. Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9. Riaz M; Raz Y; Moloney EB; van Putten M; Krom YD; van der Maarel SM; Verhaagen J; Raz V Skelet Muscle; 2015; 5():37. PubMed ID: 26561520 [TBL] [Abstract][Full Text] [Related]
35. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Broekman ML; Comer LA; Hyman BT; Sena-Esteves M Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198 [TBL] [Abstract][Full Text] [Related]